Skip to content

Startups

Stella Therapeutics

Sectors
Health & Medicine, Life Science

Graduated
Yes

Launched
01/01/2013

Description

Stella Therapeutics, a privately held drug discovery company, is developing first-in-class small molecules that hold the promise of curing Glioblastoma Multiforme (GBM), the most common and deadliest malignant brain tumor, while maintaining patient quality of life.

Team Members

Dr. Nephi Stella

Professor of Pharmacology, Psychiatry and Behavioral Sciences at the University of Washington

Elwood Howse

is currently a Director of Capstone Therapeutics (CAPS)

Steve Mattioli

has more than 25 years’ experience in founding, managing and growing technology and biotech startup companies. Currently, President & CEO of Point of Data